To provide personalized advice, they will evaluate factors such as your overall health, medical history, and particular demands
Semaglutide is a GLP 1 receptor agonist, meaning it mimics a naturally occurring hormone involved in appetite regulation, satiety signaling, and blood sugar balance
In the landmark STEP-1 clinical trial, participants receiving semaglutide 2.4 mg once weekly lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo
If most of the drug is gone, you may experience side effects if you resume the medicine at your regular dose
The time it takes for G LP injections to produce noticeable medical weight loss results can vary among individuals
History of unstable angina, myocardial infarction, coronary artery bypass graft surgery or percutaneous coronary intervention (such as angioplasty or stent placement) within 180 days of screening